Today’s agreement adds to ECO’s expanding pipeline of exciting development-stage poultry vaccines, and targets a pathogen (C. perfingens) of significant commercial importance. We look forward to further development updates with interest, and reiterate our positive stance on ECO as a core holding in the Animal Health sector, with attractive short, medium and longer-term growth prospects.
13 Feb 2019
Poultry vaccine licensing & development deal with University of Ghent
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Poultry vaccine licensing & development deal with University of Ghent
ECO Animal Health Group plc (EAH:LON) | 94.0 0 0.0% | Mkt Cap: 63.7m
- Published:
13 Feb 2019 -
Author:
Dr Jens Lindqvist -
Pages:
3
Today’s agreement adds to ECO’s expanding pipeline of exciting development-stage poultry vaccines, and targets a pathogen (C. perfingens) of significant commercial importance. We look forward to further development updates with interest, and reiterate our positive stance on ECO as a core holding in the Animal Health sector, with attractive short, medium and longer-term growth prospects.